What is Cellana?
Cellana is a science-led algae biotechnology company that has engineered an advanced outdoor, photosynthetic algae production platform. Through its merger with PhytoSmart, the company now offers a comprehensive algae-based nutrition platform, encompassing Omega-3s, plant-based proteins, and high-value ingredients for consumer and industrial applications. This integrated approach balances long-term industrial scalability with immediate revenue generation, initially targeting pet nutrition and planning expansion into human nutrition and functional foods by 2026. Cellana leverages extensive operational data and patented technologies to ensure sustainable and efficient algae cultivation.
How much funding has Cellana raised?
Cellana has raised a total of $14M across 2 funding rounds:
Unspecified
$9M
Grant
$5M
Unspecified (2010): $9M, investors not publicly disclosed
Grant (2011): $5M, investors not publicly disclosed
What's next for Cellana?
With its recent strategic investment and a substantial total funding base of $14M, Cellana is poised for significant growth. The company's focus on scaling its algae production platform, particularly for pet nutrition and its planned expansion into human nutrition and functional foods by 2026, indicates a clear trajectory toward market leadership. The enterprise-level funding suggests a mature stage of development, enabling Cellana to invest heavily in R&D, operational expansion, and market penetration. Future capital injections will likely support further technological advancements and global market entry.
See full Cellana company page
